A Fault Location Method Based on Electromagnetic Transient Convolution Considering Frequency-Dependent Parameters and Lossy Ground

As the capacity of power systems grows, the need for quick and precise short-circuit fault location becomes increasingly vital for ensuring the safe and continuous supply of power. In this paper, we propose a fault location method that utilizes electromagnetic transient convolution (EMTC). We assess the performance of a naive EMTC implementation in multi-phase power lines by using frequency-dependent parameters in real fault simulation, while using constant parameters in pre-calculation. Our results show that the location error increases as the distance between the fault location and the measurement location increases. Therefore, we adopt the aerial mode transients after phase-mode transformation to perform the convolution, which reduces the influence of frequency-dependence and ground loss. We conduct numerical experiments in a 3-phase 100-km transmission line, a radial distribution network and IEEE 9-bus system under different fault conditions. Our results show that the proposed method achieves tolerable location errors and operates efficiently through direct convolution of the real fault-generated transient signals and the pre-stored calculated transient signals

Non-collapsibility and Built-in Selection Bias of Hazard Ratio in Randomized Controlled Trials

Background: The hazard ratio of the Cox proportional hazards model is widely used in randomized controlled trials to assess treatment effects. However, two properties of the hazard ratio including the non-collapsibility and built-in selection bias need to be further investigated. Methods: We conduct simulations to differentiate the non-collapsibility effect and built-in selection bias from the difference between the marginal and the conditional hazard ratio. Meanwhile, we explore the performance of the Cox model with inverse probability of treatment weighting for covariate adjustment when estimating the marginal hazard ratio. The built-in selection bias is further assessed in the period-specific hazard ratio. Results: The conditional hazard ratio is a biased estimate of the marginal effect due to the non-collapsibility property. In contrast, the hazard ratio estimated from the inverse probability of treatment weighting Cox model provides an unbiased estimate of the true marginal hazard ratio. The built-in selection bias only manifests in the period-specific hazard ratios even when the proportional hazards assumption is satisfied. The Cox model with inverse probability of treatment weighting can be used to account for confounding bias and provide an unbiased effect under the randomized controlled trials setting when the parameter of interest is the marginal effect. Conclusions: We propose that the period-specific hazard ratios should always be avoided due to the profound effects of built-in selection bias.Comment: 17 pages, 2 figure

Efficient estimation of subgroup treatment effects using multi-source data

Investigators often use multi-source data (e.g., multi-center trials, meta-analyses of randomized trials, pooled analyses of observational cohorts) to learn about the effects of interventions in subgroups of some well-defined target population. Such a target population can correspond to one of the data sources of the multi-source data or an external population in which the treatment and outcome information may not be available. We develop and evaluate methods for using multi-source data to estimate subgroup potential outcome means and treatment effects in a target population. We consider identifiability conditions and propose doubly robust estimators that, under mild conditions, are non-parametrically efficient and allow for nuisance functions to be estimated using flexible data-adaptive methods (e.g., machine learning techniques). We also show how to construct confidence intervals and simultaneous confidence bands for the estimated subgroup treatment effects. We examine the properties of the proposed estimators in simulation studies and compare performance against alternative estimators. We also conclude that our methods work well when the sample size of the target population is much larger than the sample size of the multi-source data. We illustrate the proposed methods in a meta-analysis of randomized trials for schizophrenia

Extending Inferences from Randomized Clinical Trials to Target Populations: A Scoping Review of Transportability Methods

Objective: Randomized controlled trial (RCT) results often inform clinical decision-making, but the highly curated populations of trials and the care provided during the trial are often not reflective of real-world practice. The objective of this scoping review is to identify the ability of methods to transport findings from RCTs to target populations. Study design: A scoping review was conducted on the literature focusing on the transportability of the results from RCTs to observational cohorts. Each study was assessed based on the methodology used for transportability and the extent to which the treatment effect from the RCT was estimated in the target population in observational data. Results: A total of 15 published papers were included. The research topics include cardiovascular diseases, infectious diseases, psychiatry, oncology, orthopedics, anesthesiology, and hematology. These studies show that the findings from RCTs could be translated to real-world settings, with varying degrees of effect size and precision. In some cases, the estimated treatment effect for the target population were statistically significantly different from those in RCTs. Conclusion: Despite variations in the magnitude of effects between RCTs and real-world studies, transportability methods play an important role in effectively bridging the RCTs and real-world care delivery, offering valuable insights for evidence-based medicine

Causal inference with multiple concurrent medications: a comparison of methods and an application in multidrug-resistant tuberculosis

Simulation study code available at https://github.com/arman817/Simulation-Codes-for-Causal-Inference-for-polypharmacyThis paper investigates different approaches for causal estimation under multiple concurrent medications. Our parameter of interest is the marginal mean counterfactual outcome under different combinations of medications. We explore parametric and non-parametric methods to estimate the generalized propensity score. We then apply three causal estimation approaches (inverse probability of treatment weighting, propensity score adjustment, and targeted maximum likelihood estimation) to estimate the causal parameter of interest. Focusing on the estimation of the expected outcome under the most prevalent regimens, we compare the results obtained using these methods in a simulation study with four potentially concurrent medications. We perform a second simulation study in which some combinations of medications may occur rarely or not occur at all in the dataset. Finally, we apply the methods explored to contrast the probability of patient treatment success for the most prevalent regimens of antimicrobial agents for patients with multidrug-resistant pulmonary tuberculosis

Structured Learning in Time-dependent Cox Models

Cox models with time-dependent coefficients and covariates are widely used in survival analysis. In high-dimensional settings, sparse regularization techniques are employed for variable selection, but existing methods for time-dependent Cox models lack flexibility in enforcing specific sparsity patterns (i.e., covariate structures). We propose a flexible framework for variable selection in time-dependent Cox models, accommodating complex selection rules. Our method can adapt to arbitrary grouping structures, including interaction selection, temporal, spatial, tree, and directed acyclic graph structures. It achieves accurate estimation with low false alarm rates. We develop the sox package, implementing a network flow algorithm for efficiently solving models with complex covariate structures. Sox offers a user-friendly interface for specifying grouping structures and delivers fast computation. Through examples, including a case study on identifying predictors of time to all-cause death in atrial fibrillation patients, we demonstrate the practical application of our method with specific selection rules.Comment: 49 pages (with 19 pages of appendix),9 tables, 3 figure

Penalized G-estimation for effect modifier selection in a structural nested mean model for repeated outcomes

Effect modification occurs when the impact of the treatment on an outcome varies based on the levels of other covariates known as effect modifiers. Modeling of these effect differences is important for etiological goals and for purposes of optimizing treatment. Structural nested mean models (SNMMs) are useful causal models for estimating the potentially heterogeneous effect of a time-varying exposure on the mean of an outcome in the presence of time-varying confounding. A data-driven approach for selecting the effect modifiers of an exposure may be necessary if these effect modifiers are a priori unknown and need to be identified. Although variable selection techniques are available in the context of estimating conditional average treatment effects using marginal structural models, or in the context of estimating optimal dynamic treatment regimens, all of these methods consider an outcome measured at a single point in time. In the context of an SNMM for repeated outcomes, we propose a doubly robust penalized G-estimator for the causal effect of a time-varying exposure with a simultaneous selection of effect modifiers and use this estimator to analyze the effect modification in a study of hemodiafiltration. We prove the oracle property of our estimator, and conduct a simulation study for evaluation of its performance in finite samples and for verification of its double-robustness property. Our work is motivated by and applied to the study of hemodiafiltration for treating patients with end-stage renal disease at the Centre Hospitalier de l'Universit\'e de Montr\'eal. We apply the proposed method to investigate the effect heterogeneity of dialysis facility on the repeated session-specific hemodiafiltration outcomes

Modeling treatment effect modification in multidrug-resistant tuberculosis in an individual patient data meta-analysis

Effect modification occurs while the effect of the treatment is not homogeneous across the different strata of patient characteristics. When the effect of treatment may vary from individual to individual, precision medicine can be improved by identifying patient covariates to estimate the size and direction of the effect at the individual level. However, this task is statistically challenging and typically requires large amounts of data. Investigators may be interested in using the individual patient data (IPD) from multiple studies to estimate these treatment effect models. Our data arise from a systematic review of observational studies contrasting different treatments for multidrug-resistant tuberculosis (MDR-TB), where multiple antimicrobial agents are taken concurrently to cure the infection. We propose a marginal structural model (MSM) for effect modification by different patient characteristics and co-medications in a meta-analysis of observational IPD. We develop, evaluate, and apply a targeted maximum likelihood estimator (TMLE) for the doubly robust estimation of the parameters of the proposed MSM in this context. In particular, we allow for differential availability of treatments across studies, measured confounding within and across studies, and random effects by study

Evaluating hybrid controls methodology in early-phase oncology trials: a simulation study based on the MORPHEUS-UC trial

Phase Ib/II oncology trials, despite their small sample sizes, aim to provide information for optimal internal company decision-making concerning novel drug development. Hybrid controls (a combination of the current control arm and controls from one or more sources of historical trial data [HTD]) can be used to increase the statistical precision. Here we assess combining two sources of Roche HTD to construct a hybrid control in targeted therapy for decision-making via an extensive simulation study. Our simulations are based on the real data of one of the experimental arms and the control arm of the MORPHEUS-UC Phase Ib/II study and two Roche HTD for atezolizumab monotherapy. We consider potential complications such as model misspecification, unmeasured confounding, different sample sizes of current treatment groups, and heterogeneity among the three trials. We evaluate two frequentist methods (with both Cox and Weibull accelerated failure time [AFT] models) and three different priors in Bayesian dynamic borrowing (with a Weibull AFT model), and modifications within each of those, when estimating the effect of treatment on survival outcomes and measures of effect such as marginal hazard ratios. We assess the performance of these methods in different settings and potential of generalizations to supplement decisions in early-phase oncology trials. The results show that the proposed joint frequentist methods and noninformative priors within Bayesian dynamic borrowing with no adjustment on covariates are preferred, especially when treatment effects across the three trials are heterogeneous. For generalization of hybrid control methods in such settings we recommend more simulation studies.Comment: 34 pages, 3 figures, 5 tables. To be appear in Pharmaceutical Statistic